Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sacher

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Organic & Biomolecular Chemistry|May 30, 2013
Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondriaMarie-Céline Frantz, Erin M Skoda, Joshua R Sacher, et al.
Bone Marrow Transplantation|February 1, 1993
A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical applicationB S Charak, E M Areman, S A Dickerson, et al.
Cancer Treatment Reports|April 1, 1986
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
In Vivo (Athens, Greece)|January 9, 2017
Effectiveness of Analogs of the GS-Nitroxide, JP4-039, as Total Body Irradiation MitigatorsMichael W Epperly, Joshua R Sacher, Tanja Krainz, et al.
Investigational New Drugs|January 1, 1987
Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Cancer Letters|March 4, 2022
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivoYinan Wang, Chuanhe Yang, Michelle M Sims, et al.
Journal of Molecular and Cellular Cardiology|December 3, 2014
Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged ratsNelson Escobales, Rebeca E Nuñez, Sehwan Jang, et al.
Seminars in Hematology|July 1, 1992
Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantationT R Spitzer, M Cottler-Fox, P Sullivan, et al.
British Journal of Haematology|August 1, 1994
Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapyL T Goodnough, T H Price, C A Parvin, et al.
Transfusion|January 1, 1994
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyL T Goodnough, T H Price, K D Friedman, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Organic & Biomolecular Chemistry|May 30, 2013
Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondriaMarie-Céline Frantz, Erin M Skoda, Joshua R Sacher, et al.
Bone Marrow Transplantation|February 1, 1993
A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical applicationB S Charak, E M Areman, S A Dickerson, et al.
Cancer Treatment Reports|April 1, 1986
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
In Vivo (Athens, Greece)|January 9, 2017
Effectiveness of Analogs of the GS-Nitroxide, JP4-039, as Total Body Irradiation MitigatorsMichael W Epperly, Joshua R Sacher, Tanja Krainz, et al.
Investigational New Drugs|January 1, 1987
Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Cancer Letters|March 4, 2022
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivoYinan Wang, Chuanhe Yang, Michelle M Sims, et al.
Journal of Molecular and Cellular Cardiology|December 3, 2014
Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged ratsNelson Escobales, Rebeca E Nuñez, Sehwan Jang, et al.
Seminars in Hematology|July 1, 1992
Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantationT R Spitzer, M Cottler-Fox, P Sullivan, et al.
British Journal of Haematology|August 1, 1994
Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapyL T Goodnough, T H Price, C A Parvin, et al.
Transfusion|January 1, 1994
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyL T Goodnough, T H Price, K D Friedman, et al.
Pageof 5